The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of panobinostat with ipilimumab in advanced melanoma.
 
Nikhil I. Khushalani
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Castle Biosciences; EMD Serono
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); GlaxoSmithKline; Merck (Inst); NCCN (Inst); Novartis (Inst); Pfizer (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Joseph Markowitz
Consulting or Advisory Role - Idera; Newlink Genetics
Research Funding - Genoptix (Inst); Macrogenics (Inst); Morphogenesis (Inst); Reata Pharmaceuticals (Inst)
 
Zeynep Eroglu
No Relationships to Disclose
 
Iulia Giuroiu
No Relationships to Disclose
 
Viktoriya Ladanova
No Relationships to Disclose
 
Pamela Reiersen
No Relationships to Disclose
 
Jeani Rich
No Relationships to Disclose
 
Ram Thapa
No Relationships to Disclose
 
Michael J. Schell
No Relationships to Disclose
 
Eduardo M. Sotomayor
No Relationships to Disclose
 
Jeffrey S. Weber
Stock and Other Ownership Interests - Altor BioScience; Celldex; CytomX Therapeutics
Honoraria - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Medivation; Merck; Merck; Nektar; Novartis; Pieris Pharmaceuticals; Roche
Consulting or Advisory Role - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Medivation; Merck; Merck; Nektar; Novartis; Pieris Pharmaceuticals; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - named on a patent from Biodesix for a PD-1 antibody biomarker; Named on a patent submitted by Moffitt Cancer Center for an IPILIMUMAB biomarker
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Genentech; GlaxoSmithKline; Lion Biotechnologies; Merck; Merck; Novartis; Pieris Pharmaceuticals; Roche